Arshad A Pandith Selected Research

Neoplasms (Cancer)

12/2021	Analysis of MNS16A VNTR polymorphic sequence variations of the TERT gene and associated risk for development of bladder cancer.
8/2021	Significant Implications of APOA1 Gene Sequence Variations and Its Protein Expression in Bladder Cancer.
11/2020	Association of strong risk of hTERT gene polymorphic variants to malignant glioma and its prognostic implications with respect to different histological types and survival of glioma cases.
1/2018	ACE I/D sequence variants but not MTHFR C677T, is strongly linked to malignant glioma risk and its variant DD genotype may act as a promising predictive biomarker for overall survival of glioma patients.
1/2015	Significant association of TP53 Arg72Pro polymorphism in susceptibility to differentiated thyroid cancer.
11/2014	Epigenetic silencing of TSHR gene in thyroid cancer patients in relation to their BRAF V600E mutation status.
8/2014	MGMT gene silencing by promoter hypermethylation in gastric cancer in a high incidence area.
2/2013	Lack of mutational events of RAS genes in sporadic thyroid cancer but high risk associated with HRAS T81C single nucleotide polymorphism (case-control study).
10/2012	Burden of cancers in the valley of Kashmir: 5 year epidemiological study reveals a different scenario.
8/2012	Impact of codon 72 Arg > Pro single nucleotide polymorphism in TP53 gene in the risk of kangri cancer: a case control study in Kashmir.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arshad A Pandith Research Topics

Disease

14	Neoplasms (Cancer) 12/2021 - 01/2009
6	Urinary Bladder Neoplasms (Bladder Cancer) 08/2021 - 01/2010
4	Glioma (Gliomas) 12/2020 - 01/2018
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2021 - 06/2018
3	Thyroid Neoplasms (Thyroid Cancer) 01/2015 - 02/2013
2	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 07/2017
2	Acute Promyelocytic Leukemia 01/2019 - 01/2016
2	Colorectal Neoplasms (Colorectal Cancer) 05/2018 - 06/2011
2	Papillary Thyroid Cancer 08/2015 - 03/2014
2	Carcinogenesis 03/2014 - 05/2013
1	Habitual Abortion (Recurrent Miscarriage) 05/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2018
1	follicular Thyroid cancer 08/2015
1	Stomach Neoplasms (Stomach Cancer) 08/2014
1	Breast Neoplasms (Breast Cancer) 10/2012
1	Esophageal Neoplasms (Esophageal Cancer) 10/2012
1	Transitional Cell Carcinoma 01/2010
1	Carcinoma (Carcinomatosis) 01/2009

Drug/Important Bio-Agent (IBA)

6	Codon (Codons)IBA 01/2015 - 10/2009
4	Proteins (Proteins, Gene)FDA Link 08/2021 - 03/2014
3	Tyrosine Kinase InhibitorsIBA 10/2021 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 08/2021 - 01/2018
3	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 01/2009
2	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2021 - 11/2020
2	Glutathione Transferase (Glutathione S-Transferase)IBA 10/2021 - 01/2021
2	Imatinib Mesylate (Gleevec)FDA Link 10/2021 - 06/2018
2	EnzymesIBA 10/2021 - 01/2021
2	ArsenicIBA 01/2019 - 01/2016
2	OxidesIBA 01/2019 - 01/2016
2	Calcibiotic Root Canal SealerIBA 05/2018 - 06/2011
2	NucleotidesIBA 02/2013 - 08/2011
2	Proline (L-Proline)FDA Link 08/2012 - 12/2010
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 08/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2021
1	CytokinesIBA 05/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2019
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2018
1	Netrin ReceptorsIBA 05/2018
1	Biological ProductsIBA 01/2018
1	MethyltransferasesIBA 01/2018
1	Alkylating AgentsIBA 01/2018
1	Gefitinib (Iressa)FDA Link 01/2018
1	Temozolomide (Temodar)FDA LinkGeneric 01/2018
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 07/2017
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2016
1	RacivirIBA 08/2015
1	Phosphotransferases (Kinase)IBA 11/2014
1	Indicators and Reagents (Reagents)IBA 03/2014
1	Valine (L-Valine)FDA Link 03/2014
1	Glutamine (L-Glutamine)FDA Link 03/2014
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 05/2013
1	TOPSIBA 10/2012
1	arginylprolineIBA 08/2012
1	NAD (NADH)IBA 08/2011
1	Oxidoreductases (Dehydrogenase)IBA 08/2011
1	quinone (benzoquinone)IBA 08/2011
1	nuclear matrix protein 22IBA 01/2010

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2021 - 01/2018
1	Radiotherapy 01/2018